Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2007-09-11 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE AND CONNECTED TRANSACTION IN RESPECT OF ACQUISITION OF 49% EQUITY INTEREST IN OCT INVESTMENTS LIMITED AND PROPOSED CHANGE OF NAME OF THE COMPANY
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular issued by Huali Holdings (Group) Limited regarding a discloseable and connected transaction involving the acquisition of 49% equity interest in OCT Investments Limited and a proposed change of the company's name. It includes detailed information such as letters from the Board, Independent Board Committee, and Independent Financial Adviser, a valuation report, general information, and a notice of an extraordinary general meeting (EGM) to approve the transaction and name change. The document is comprehensive and intended to inform shareholders and solicit their approval at the EGM. This type of document is typically classified as a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to enable them to make informed voting decisions at a general meeting. It is not merely an announcement or a brief notice, but a full circular with detailed disclosures and meeting notice.
2007-09-11 English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RESPECT OF ACQUISITION OF 49% EQUITY INTEREST IN OCT INVESTMENTS LIMITED AND PROPOSED CHANGE OF NAME OF THE COMPANY
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for an Extraordinary General Meeting (EGM) of Huali Holdings (Group) Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the EGM, including approval of a share transfer agreement and a company name change. The content is procedural and related to voting arrangements rather than the results of the vote or the meeting itself. It is not a report, announcement of voting results, or management information. The document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2007-09-11 English
Unusual price and trading volume movement
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding unusual price and trading volume movements of the company's shares. It explicitly states that there are no negotiations or agreements related to acquisitions or realizations, and no price-sensitive information to disclose. The document is signed by the company secretary and includes a date. There is no financial data, no detailed report, no meeting materials, or voting results. The content fits the profile of a regulatory announcement about market activity and company disclosures, which aligns with the Regulatory Filings (RNS) category. The document length is short (1113 characters), and it is not a report or presentation but a regulatory announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2007-09-03 English
Interim Report 2007
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial data and analysis for the six months ended 30 June 2007, including turnover, profit margins, expenses, interest costs, liquidity ratios, and capital structure. It also includes management discussion and analysis of operating results, business review, outlook, and strategic plans. The presence of comprehensive financial statements and substantive financial data for a half-year period indicates this is a financial report for an interim period. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. The title and content explicitly mention 'Interim Financial Report' and the period covered is the first half of 2007, which aligns with the definition of an Interim / Quarterly Report (IR). Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2007
2007-08-29 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short exchange notice regarding the resumption of trading for a specific stock. It does not contain financial statements, management reports, or other substantive disclosures, but rather serves as a regulatory notification to the market. As it does not fit into specific categories like M&A or share issues, it falls under the general regulatory filing category.
2007-08-27 English
(I)DISCLOSEABLE AND CONNECTED TRANSACTION: ACQUISITION OF 49% EQUITY INTEREST IN OCT INVESTMENTS LIMITED (II)PLACING OF EXISTING SHARES AND SUBSCRIPTION OF NEW SHARES (III)PROPOSED CHANGE OF NAME
Capital/Financing Update Classification · 95% confidence The document is an announcement from Huali Holdings (Group) Limited regarding multiple corporate actions: a discloseable and connected transaction involving the acquisition of 49% equity interest in OCT Investments Limited, a placing of existing shares and subscription of new shares, a proposed change of company name, and resumption of trading. The text includes detailed terms of the share transfer agreement, placing and subscription agreement, and conditions precedent. It also references the Listing Rules and the need for shareholder approval at an extraordinary general meeting. The document is lengthy (15,000 characters) and contains detailed transaction terms and corporate actions rather than just a brief announcement or a report. It is not a full annual or interim financial report, nor an earnings release or audit report. It is a formal announcement of a capital/financing transaction and related corporate actions. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2007-08-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.